Osteomark

Osteomark®

Metabolism A proprietary urine test for measuring bone loss, quantifying cross-linked N-telopeptides–NTx, which are degradation products of bone resorption and are unique biochemical markers specific for the type I collagen–found in bone. See Hormone replacement therapy, N-telopeptides, Osteoporosis.
References in periodicals archive ?
A group of researchers compared the Pyrilinks-D test to other bone resorption tests like Osteomark and CrossLaps.
A urine test developed by OSTEOMARK can determine whether a woman's body is losing bone density.
sALP was determined by the Tandem-MP Ostase Immunoenzymetric Assay (Beckman Coulter) (10) and NTx by the Osteomark NTx Assay (Ostex International) (11).